Effettuare il login Iscriviti gratis

Alimera Sciences Entrate Y/Y

Cos'è Entrate Y/Y di Alimera Sciences?

Entrate Y/Y di Alimera Sciences Inc. è 69.78%

Qual è la definizione di Entrate Y/Y?

La crescita annuale dei ricavi degli ultimi 3 anni è la crescita dei ricavi da un anno all'altro in media negli ultimi 3 anni.

The yearly revenue growth rate is calculated as the percentage change in revenue over the trailing twelve months. For this specific metric, the calculation takes into account a series of the last eight quarterly revenues. The revenue growth is useful for determining the success of the company expanding its main business. Revenue growth of 5% to 10% is usually considered good for large-cap companies. For other companies, a sales growth of over 10% is more desirable.

Entrate Y/Y di aziende nel Health Care settore su NASDAQ rispetto a Alimera Sciences

Cosa fa Alimera Sciences?

alimera, founded in june 2003, is a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. alimera is presently focused on diseases affecting the back of the eye, or retina, because these diseases are not well treated with current therapies and will affect millions of people in aging populations. alimera's commitment to retina specialists and their patients is manifest in its product and in its development portfolio designed to treat early- and late-stage diseases. for more information, please visit www.alimerasciences.com. alimera's european operations are conducted from london by its subsidiary, alimera sciences limited.

Aziende con entrate y/y simili a Alimera Sciences